Antoniu SA - Search Results

1

Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective.

Cojocaru E, Cojocaru C, Antoniu SA, Stafie CS, Rajnoveanu A, Rajnoveanu RM. Cojocaru E, et al. Among authors: antoniu sa. Expert Rev Respir Med. 2022 Mar;16(3):257-261. doi: 10.1080/17476348.2022.2008910. Epub 2021 Dec 2. Expert Rev Respir Med. 2022. PMID: 34793285 Free PMC article.

2

MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections.

Azoicai D, Antoniu SA. Azoicai D, et al. Among authors: antoniu sa. Expert Opin Investig Drugs. 2013 Feb;22(2):267-76. doi: 10.1517/13543784.2013.748034. Epub 2012 Nov 24. Expert Opin Investig Drugs. 2013. PMID: 23176385 Review.

3

Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.

Antoniu SA, Antohe I. Antoniu SA, et al. Expert Opin Pharmacother. 2013 May;14(7):967-9. doi: 10.1517/14656566.2013.783015. Epub 2013 Mar 21. Expert Opin Pharmacother. 2013. PMID: 23514606 Review.

4

Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.

Antoniu S. Antoniu S. Expert Rev Anti Infect Ther. 2015 Jul;13(7):897-905. doi: 10.1586/14787210.2015.1041925. Epub 2015 Apr 28. Expert Rev Anti Infect Ther. 2015. PMID: 25921312

5

Nivolumab for advanced non-small cell lung cancer: an evaluation of a phase III study.

Ulmeanu R, Antohe I, Anisie E, Antoniu S. Ulmeanu R, et al. Expert Rev Anticancer Ther. 2016;16(2):165-7. doi: 10.1586/14737140.2016.1127760. Epub 2016 Jan 12. Expert Rev Anticancer Ther. 2016. PMID: 26634873

6

Benralizumab as a potential treatment of asthma.

Antoniu SA. Antoniu SA. Expert Opin Biol Ther. 2017 Jul;17(7):895-900. doi: 10.1080/14712598.2017.1319471. Epub 2017 Apr 19. Expert Opin Biol Ther. 2017. PMID: 28406319 Review.

7

Triple fixed inhaled therapy in frequent chronic obstructive pulmonary disease exacerbators: potential advantages for various degrees of airways obstruction.

Antohe I, Antoniu SA, Gavrilovici C. Antohe I, et al. Among authors: antoniu sa. Expert Opin Pharmacother. 2018 Feb;19(3):287-289. doi: 10.1080/14656566.2017.1419186. Epub 2017 Dec 22. Expert Opin Pharmacother. 2018. PMID: 29271268

8

Investigational inhaled therapies for non-CF bronchiectasis.

Antoniu SA. Antoniu SA. Expert Opin Investig Drugs. 2018 Feb;27(2):139-146. doi: 10.1080/13543784.2018.1427728. Epub 2018 Jan 25. Expert Opin Investig Drugs. 2018. PMID: 29338445 Review.

9

Evaluating revefenacin as a therapeutic option for chronic obstructive pulmonary disease.

Antoniu SA, Rajnoveanu R, Ulmeanu R, Mihaltan F, Grigore M. Antoniu SA, et al. Expert Opin Pharmacother. 2020 Jun;21(9):997-1004. doi: 10.1080/14656566.2020.1745185. Epub 2020 Apr 1. Expert Opin Pharmacother. 2020. PMID: 32237914

10

Pharmacotherapy options in pulmonary alveolar proteinosis.

Antoniu SA, Rajnoveanu R, Grigore M, Antohe I. Antoniu SA, et al. Expert Opin Pharmacother. 2020 Aug;21(11):1359-1366. doi: 10.1080/14656566.2020.1757650. Epub 2020 Jun 8. Expert Opin Pharmacother. 2020. PMID: 32511020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page